141 related articles for article (PubMed ID: 17906702)
1. The evolving background for high-dose treatment for myeloma.
Sirohi B; Powles R; Harousseau JL; Anderson KC
Bone Marrow Transplant; 2007 Dec; 40(12):1097-100. PubMed ID: 17906702
[TBL] [Abstract][Full Text] [Related]
2. Targeted treatments to improve stem cell outcome: old and new drugs.
Raab MS; Breitkreutz I; Anderson KC
Bone Marrow Transplant; 2007 Dec; 40(12):1129-37. PubMed ID: 17768392
[TBL] [Abstract][Full Text] [Related]
3. Role of autologous stem-cell transplantation in multiple myeloma.
Attal M; Harousseau JL
Best Pract Res Clin Haematol; 2007 Dec; 20(4):747-59. PubMed ID: 18070717
[TBL] [Abstract][Full Text] [Related]
4. High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future.
Björkstrand B; Gahrton G
Semin Hematol; 2007 Oct; 44(4):227-33. PubMed ID: 17961721
[TBL] [Abstract][Full Text] [Related]
5. Current status of autologous hematopoietic stem cell transplantation in myeloma.
Mehta J; Singhal S
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S28-S34. PubMed ID: 18724294
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years.
Mehta J; Singhal S
Bone Marrow Transplant; 2007 Dec; 40(12):1101-14. PubMed ID: 17680020
[TBL] [Abstract][Full Text] [Related]
7. Treatment of multiple myeloma in the targeted therapy era.
Saad AA; Sharma M; Higa GM
Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585
[TBL] [Abstract][Full Text] [Related]
8. Management of newly diagnosed myeloma.
Rajkumar SV; Palumbo A
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1141-56, ix-x. PubMed ID: 17996592
[TBL] [Abstract][Full Text] [Related]
9. Autologous stem cell transplantation in the elderly including pre- and post-treatment options.
Kumar SK; Hayman SR; Kyle RA
Bone Marrow Transplant; 2007 Dec; 40(12):1115-21. PubMed ID: 17680019
[TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma--an update on diagnosis and treatment.
Caers J; Vande broek I; De Raeve H; Michaux L; Trullemans F; Schots R; Van Camp B; Vanderkerken K
Eur J Haematol; 2008 Nov; 81(5):329-43. PubMed ID: 18637123
[TBL] [Abstract][Full Text] [Related]
11. Stem-cell transplantation for multiple myeloma in the era of novel drugs.
Bensinger W
J Clin Oncol; 2008 Jan; 26(3):480-92. PubMed ID: 18056678
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib in the front-line treatment of multiple myeloma.
Richardson PG; Mitsiades C; Schlossman R; Ghobrial I; Hideshima T; Munshi N; Anderson KC
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1053-72. PubMed ID: 18588451
[TBL] [Abstract][Full Text] [Related]
13. Advances in therapy of multiple myeloma.
Bladé J; Rosiñol L
Curr Opin Oncol; 2008 Nov; 20(6):697-704. PubMed ID: 18841053
[TBL] [Abstract][Full Text] [Related]
14. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
[TBL] [Abstract][Full Text] [Related]
15. Clinical updates and nursing considerations for patients with multiple myeloma.
Faiman B
Clin J Oncol Nurs; 2007 Dec; 11(6):831-40. PubMed ID: 18063542
[TBL] [Abstract][Full Text] [Related]
16. [The importance of autologous transplantation in multiple myeloma].
Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
[TBL] [Abstract][Full Text] [Related]
17. Management of multiple myeloma: the changing landscape.
Reece DE
Blood Rev; 2007 Nov; 21(6):301-14. PubMed ID: 17761373
[TBL] [Abstract][Full Text] [Related]
18. Conventional therapy and approach to management.
Rajkumar SV; Kyle RA
Best Pract Res Clin Haematol; 2005; 18(4):585-601. PubMed ID: 16026739
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study.
Feyler S; Rawstron A; Jackson G; Snowden JA; Cocks K; Johnson RJ
Br J Haematol; 2007 Nov; 139(3):429-33. PubMed ID: 17910633
[TBL] [Abstract][Full Text] [Related]
20. Melphalan and its role in the management of patients with multiple myeloma.
Falco P; Bringhen S; Avonto I; Gay F; Morabito F; Boccadoro M; Palumbo A
Expert Rev Anticancer Ther; 2007 Jul; 7(7):945-57. PubMed ID: 17627453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
